Preeclampsia Clinical Trial
Official title:
Is There Any Relationship Between First Trimester (11-14 Weeks of Pregnancy) Fetal Thymus Volume and Preeclampsia? Prospective Cohort Study.
NCT number | NCT04264247 |
Other study ID # | 2016/176 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 1, 2017 |
Est. completion date | January 17, 2019 |
Verified date | March 2019 |
Source | Karadeniz Technical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The exact etiology of preeclampsia remains unclear but is known to involve immunological
factors. The thymus is one of the main organs involved in the development of the fetal immune
system. The aim of this study was to explore the association between fetal thymus volume on
ultrasound and preeclampsia by adding the 3-dimensional measurement of thymus volume to the
routine fetal ultrasound scan at 11-14 week of gestation.
Investigators performed a prospective clinical study in 100 pregnant women in their first
trimester of pregnancy who attended the Fetal Medicine Unit of the Medicine Faculty of
Karadeniz Technical University during the study period. Maternal age, gravida, para, BMI,
blood pressure, gestational age, CRL and fetal timus volume measured with VOCAL programme are
recorded. For all patients routine clinical and ultrasound examinations were performed during
pregnancy. Gestational age at birth, way of birth and newborn birthweight were recorded. The
results were statistically compared in the SPSS 13.0 program. Student-t test and chi-square
test were used for statistical analysis. ROC curve analysis was used for limit values. The
data of patients with preeclampsia and without preeclampsia were compared. The ability of the
thymus volume to predict the preeclampsia was tested using binary logistic regression
analysis. P value <0.05 was considered statistically significant.
Status | Completed |
Enrollment | 100 |
Est. completion date | January 17, 2019 |
Est. primary completion date | January 1, 2018 |
Accepts healthy volunteers | |
Gender | Female |
Age group | 18 Years to 35 Years |
Eligibility |
Inclusion Criteria: - 11-14 weeks pregnancy with no abnormal ultrasonography evidence. Exclusion Criteria: Any history of obstetric complications Chronic hypertension Diabetes mellitus Infectious or autoimmune disease. |
Country | Name | City | State |
---|---|---|---|
Turkey | Karadeniz Technical University | Trabzon |
Lead Sponsor | Collaborator |
---|---|
Karadeniz Technical University |
Turkey,
Mohamed N, Eviston DP, Quinton AE, Benzie RJ, Kirby AC, Peek MJ, Nanan RK. Smaller fetal thymuses in pre-eclampsia: a prospective cross-sectional study. Ultrasound Obstet Gynecol. 2011 Apr;37(4):410-5. doi: 10.1002/uog.8953. Epub 2011 Mar 7. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Preeclampsia | Hypertension (Sistolik blood pressure >140, diastolic blood pressure >90), Proteinuria (>0.3 g proteinuria in 24 hour collected urine sample) | At least after 10 weeks of initial examination. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03510286 -
Validation of a PrCr Dipstick Diagnostic Test in Ghana
|
||
Recruiting |
NCT03313024 -
Berlin-Brandenburg Pregnancy Cohort
|
||
Active, not recruiting |
NCT04990141 -
Molecular Screening Method for Preeclampsia (PREMOM)
|
||
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT05999851 -
Multiparametric Assessment of Maternal Vascular Function in the Prediction of Hypertensive Disorders of Pregnancy
|
N/A | |
Recruiting |
NCT02923206 -
Proof-of-Concept Trial on Selective Removal of sFlt-1 in Pregnant Women With Preeclampsia Via Apheresis
|
N/A | |
Completed |
NCT02554604 -
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
|
||
Not yet recruiting |
NCT02541110 -
Prediction of Preeclampsia & Other Obstetric Complications by Serum Homocysteine & Doppler
|
N/A | |
Withdrawn |
NCT05016440 -
Lisinopril for Renal Protection in Postpartum Preeclamptic Women
|
N/A | |
Completed |
NCT02384226 -
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
|
||
Completed |
NCT02854501 -
Second Trimester Maternal Serum Homocysteine Levels and Uterine Artery Doppler for Prediction of Preeclampsia and Placentation Disorders
|
||
Terminated |
NCT02558023 -
The Treatment of Hypertension Associated With Severe Preeclampsia (PE). A Trial of Urapidil Versus Nicardipine
|
Phase 3 | |
Recruiting |
NCT02247297 -
Pancreatic Stone Protein (PSP) in Pregnant Women
|
||
Recruiting |
NCT02337049 -
Preeclampsia Subtypes and Surrogate Markers of CVD Risk
|
N/A | |
Completed |
NCT02238704 -
Cornell University-Micronutrient Initiative Calcium Supplementation Study
|
N/A | |
Withdrawn |
NCT01179542 -
The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR
|
N/A | |
Completed |
NCT01195441 -
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
|
N/A | |
Completed |
NCT00456118 -
Study of the Role of Tissular Maternofetal Alloimmunization in Placentation Pathologies
|
||
Recruiting |
NCT00117546 -
Cardiovascular and Autonomic Reactivity in Women With a History of Pre-eclampsia
|
Phase 4 | |
Completed |
NCT00787241 -
Platelet Count Trends in Pre-eclamptic Parturients
|
N/A |